Shah, Eric D <br/><br/>
Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  03 2020 
 - 527-533 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Systematic Review 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.15637  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Adverse Drug Reaction Reporting Systems--statistics & numerical data<br/>Aged<br/>Aged, 80 and over<br/>Biological Products--therapeutic use<br/>Child<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Liver Neoplasms--chemically induced<br/>Lymphoma, T-Cell--chemically induced<br/>Male<br/>Middle Aged<br/>Splenic Neoplasms--chemically induced<br/>United States--epidemiology<br/>United States Food and Drug Administration<br/>Young Adult